<?xml version="1.0" encoding="UTF-8"?><html xmlns="http://www.w3.org/1999/xhtml" xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:obo="http://purl.obolibrary.org/obo/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:xsd="http://www.w3.org/2001/XMLSchema#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:dublincorens="http://purl.org/dc/elements/1.1/"  version="XHTML+RDFa 1.0" ><body>Molecular Microbiology (2013) 90(2), 443&#226;&#8364;&#8220;455 &#226;&#8211;&#160;                                                             doi:10.1111/mmi.12376 <br />                                                                                          published online 9 September 2013 <br />  <br />  <br />  <br /> Trypanosoma brucei (<span id='am-115' about='obo:IMR_0200409' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-116' property="oboInOwl:id" content="IMR:0200409" datatype="xsd:string"></span><span id='am-117' property="rdfs:label" content="UMP" datatype="xsd:string"></span><span id='am-118' property="oboInOwl:hasDbXref" content="KEGG:C00105" datatype="xsd:string"></span><span id='am-119' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>UMP</span> synthase null mutants) avirulent mice, recover virulence prolonged <br /> culture vitro retaining pyrimidine auxotrophy <br />  <br /> Han B. Ong, Natasha Sienkiewicz,&#226;&#8364;&#160; Susan Wyllie,                   Introduction <br /> Stephen Patterson Alan H. Fairlamb* <br /> Divisional Biological Chemistry Drug Discovery,            neglected tropical disease human African trypanoso- <br /> College Life Sciences, University Dundee, Dundee            miasis (HAT) caused subspecies proto- <br /> DD1 5EH, UK.                                                      zoan parasite Trypanosoma brucei (T. b. gambiense                                                                   T. b. rhodesiense). Current drugs used treatment <br />                                                                   disease far ideal plagued Summary                                                           disadvantages, high cost, toxic effects, drug <br />                                                                   resistance lack oral bioavailability (Fairlamb, 2003; <br /> African trypanosomes capable novo <br />                                                                   Stuart et al., 2008). order develop suitable synthesis salvage pyrimidines.                                                                   effective drugs, enzymes essential metabolic pathways <br /> steps novo synthesis catalysed UMP <br />                                                                   assessed potential drug targets. synthase (UMPS) &#226;&#8364;&#8220; bifunctional enzyme comprising <br />                                                                   pathway examined pyrimidine metabolism orotate phosphoribosyl transferase (OPRT) oro- <br />                                                                   T. brucei. <br /> tidine monophosphate decarboxylase (OMPDC).                                                                      Pyrimidine (deoxy)-nucleotides essential <br /> investigate essentiality pyrimidine biosynthe- <br />                                                                   precursors synthesis RNA DNA, sis Trypanosoma brucei, generated umps <br />                                                                   <span id='am-24' about='obo:IMR_0200468' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-25' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-26' property="oboInOwl:id" content="IMR:0200468" datatype="xsd:string"></span><span id='am-27' property="rdfs:label" content="CDP" datatype="xsd:string"></span><span id='am-28' property="oboInOwl:hasDbXref" content="KEGG:C00112" datatype="xsd:string"></span>CDP</span> <span id='am-145' about='obo:IMR_0200206' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-146' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-147' property="oboInOwl:hasDbXref" content="KEGG:C00015" datatype="xsd:string"></span><span id='am-148' property="rdfs:label" content="UDP" datatype="xsd:string"></span><span id='am-149' property="oboInOwl:id" content="IMR:0200206" datatype="xsd:string"></span>UDP</span> conjugates biosynthesis glycocon- <br /> double knockout (DKO) line gene replacement. <br />                                                                   jugates, complex lipids  organisms, isopre- DKO unable grow pyrimidine-depleted <br />                                                                   noids  non-mevalonate pathway), medium vitro, unless supplemented <span id='am-125' about='obo:IMR_0200234' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-126' property="oboInOwl:id" content="IMR:0200234" datatype="xsd:string"></span><span id='am-127' property="oboInOwl:hasDbXref" content="KEGG:C00106" datatype="xsd:string"></span><span id='am-128' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-129' property="rdfs:label" content="Uracil" datatype="xsd:string"></span>uracil</span>, <br />                                                                   secondary metabolism plants xenobiotic <br /> <span id='am-110' about='obo:IMR_0200021' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-111' property="oboInOwl:id" content="IMR:0200021" datatype="xsd:string"></span><span id='am-112' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-113' property="oboInOwl:hasDbXref" content="KEGG:C00299" datatype="xsd:string"></span><span id='am-114' property="rdfs:label" content="Uridine" datatype="xsd:string"></span>uridine</span>, deoxyuridine UMP. DKO parasites                                                                   metabolism animals. cells, including trypano- <br /> completely resistant 5-fluoroorotate hypersen- <br />                                                                   somes (Hammond Gutteridge, 1984), obtain sitive 5-fluorouracil, consistent loss UMPS, <br />                                                                   pyrimidine requirement novo biosynthe- remained sensitive pyrazofurin indicating  <br />                                                                   sis salvage pathways (Fig. 1). novo biosyn- <br /> unlike mammalian cells, primary target pyrazo- <br />                                                                   thetic pathway, precursor bicarbonate converted <br /> furin OMPDC. null mutant unable                                                                   <span id='am-140' about='obo:IMR_0200109' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-141' property="oboInOwl:hasDbXref" content="KEGG:C00169" datatype="xsd:string"></span><span id='am-142' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-143' property="oboInOwl:id" content="IMR:0200109" datatype="xsd:string"></span><span id='am-144' property="rdfs:label" content="Carbamoyl phosphate" datatype="xsd:string"></span>carbamoyl phosphate</span> carbamoyl phosphate syn- <br /> infect mice indicating salvage host pyrimi- <br />                                                                   thase aspartate carbamoyltransferase cycliza- <br /> dines insufficient support growth.  fol- <br />                                                                   tion form dihydroorotate dihydroorotase. lowing prolonged culture vitro, parasites regained <br />                                                                   enzymes fused humans (CAD protein) virulence mice despite retaining pyrimidine aux- <br />                                                                   separate trypanosomatids. Dihydroorotate otrophy. Unlike wild-type, pyrimidine aux- <br />                                                                   converted dihydroorotate dehydrogenase (DHOD) otrophs secreted substantial quantities orotate, <br />                                                                   form <span id='am-39' about='obo:IMR_0200265' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-40' property="oboInOwl:id" content="IMR:0200265" datatype="xsd:string"></span><span id='am-41' property="oboInOwl:hasDbXref" content="KEGG:C00295" datatype="xsd:string"></span><span id='am-42' property="rdfs:label" content="Orotic acid" datatype="xsd:string"></span><span id='am-43' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>orotic acid</span>. human enzyme (Enzyme Commis- <br /> significantly higher virulent DKO line. pro- <br />                                                                   sion number 1.3.5.2), located mitochondrial <br /> pose responsible recovery                                                                   membrane transfers electrons <span id='am-29' about='obo:IMR_0200483' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-30' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-31' property="oboInOwl:id" content="IMR:0200483" datatype="xsd:string"></span><span id='am-32' property="rdfs:label" content="Ubiquinone" datatype="xsd:string"></span><span id='am-33' property="oboInOwl:hasDbXref" content="KEGG:C00399" datatype="xsd:string"></span>ubiquinone</span>, virulence mice, host metabolism converting <br />                                                                   target immunomodulatory drug, leflunomide, used <br /> orotate uridine, bypassing loss                                                                   treat rheumatoid arthritis (Herrmann et al., 2000). UMPS parasite. <br />                                                                   contrast, trypanosomal enzyme (EC 1.3.98.1)                                                                   located cytosol uses fumarate electron <br />                                                                   <span id='am-130' about='obo:IMR_0200224' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-131' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-132' property="oboInOwl:hasDbXref" content="KEGG:C00028" datatype="xsd:string"></span><span id='am-133' property="rdfs:label" content="Acceptor" datatype="xsd:string"></span><span id='am-134' property="oboInOwl:id" content="IMR:0200224" datatype="xsd:string"></span>acceptor</span> (Arakaki et al., 2008). RNAi knockdown Accepted 22 August, 2013.  correspondence. E-mail             DHOD T. brucei reported retard growth h.fairlamb@dundee.ac.uk; Tel. (+44) 1382 385155; Fax (+44)      vitro pyrimidine-depleted medium DHOD-deficient <br /> 1382 385542. &#226;&#8364;&#160;Present address: Integrated Magnetic Systems  <br /> Prospect Business Centre, Gemini Crescent, Dundee Technology      trypanosomes hypersensitive 5-fluorouracil <br /> Park, Dundee DD2 1TY, UK.                                         (Arakaki et al., 2008). umps null  <br /> &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley <span id='am-12' about='obo:IMR_0200083' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-13' property="oboInOwl:hasDbXref" content="KEGG:C00020" datatype="xsd:string"></span><span id='am-14' property="oboInOwl:hasExactSynonym" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-15' property="rdfs:label" content="AMP" datatype="xsd:string"></span><span id='am-16' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-17' property="rdfs:label" content="Adenosine 5&apos;-monophosphate" datatype="xsd:string"></span><span id='am-18' property="oboInOwl:id" content="IMR:0200083" datatype="xsd:string"></span>amp</span>; Sons  open access article terms Creative Commons Attribution License, permits use, distribution reproduction medium, provided original work properly cited. <br />  444 H. B. Ong et al. &#226;&#8211;&#160; <br />  <br />                                                                                                              uridine                  uracil <br />  <br />  <br />  <br />  <br />                                                                                           O <br />                                                                                                    R                                                            O <br />                                                                                      HN <br />                                                                                                                             UPase                          HN <br />                                                                                                                                                                     R <br />                                                                                   O       N            uridine                                   uracil <br />                                                                                                                                                           O     N <br />                                                                        HO                                                                                       H <br />                                                                                      O                                     Pi   Ribose-1-P <br />  <br />  <br />                                                                               OH         OH <br />                                                                                                                                           PRPP <br />                                                                                                                                                           UPRT <br />  <br />  <br />                                                                                                    O                                                  O <br />                                                                                                          R                                                 R <br />                                                                                               HN                                                 HN <br />                                      O <br />                                                                                           O        N     COO-                                  O      N <br />                                               R          OPRT                                                 OMPDC                                                     RNA, DNA &amp; <br />    HCO3- + Gln                  HN <br />                                                                         2-O PO                                                   2-O PO <br />    + <span id='am-49' about='obo:IMR_0001351' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-50' property="rdfs:label" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-51' property="oboInOwl:hasAlternativeId" content="IMR:0100127" datatype="xsd:string"></span><span id='am-52' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-53' property="rdfs:label" content="ATP" datatype="xsd:string"></span><span id='am-54' property="oboInOwl:hasExactSynonym" content="adenosine triphosphate" datatype="xsd:string"></span><span id='am-55' property="rdfs:label" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span><span id='am-56' property="oboInOwl:hasAlternativeId" content="IMR:0200394" datatype="xsd:string"></span><span id='am-57' property="oboInOwl:id" content="IMR:0001351" datatype="xsd:string"></span><span id='am-58' property="oboInOwl:hasDbXref" content="KEGG:C00002" datatype="xsd:string"></span><span id='am-59' property="oboInOwl:hasExactSynonym" content="adenosine 5&apos;-triphosphate" datatype="xsd:string"></span>ATP</span> + Asp <br />                                                                            3              O                                         3          O                          sugar <br />                                O     N        COO- <br />                                      H <br />                                                          PRPP                                                          <span id='am-19' about='obo:IMR_0200324' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-20' property="oboInOwl:id" content="IMR:0200324" datatype="xsd:string"></span><span id='am-21' property="oboInOwl:hasDbXref" content="KEGG:C00011" datatype="xsd:string"></span><span id='am-22' property="rdfs:label" content="CO2" datatype="xsd:string"></span><span id='am-23' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>CO2</span>                                              nucleotides <br />                                                                                          OH    OH                                           OH     OH <br />  <br />                                                                                orotidine                                                 uridine <br />                                orotate <br />                                                                              monophosphate                                            monophosphate <br />  <br />                                                               O                                                             O <br />                                                                   NH2                                                           NH2 <br />                                                          HN                                                           HN <br />                                                          N                                                             N        OH <br />                                                                   OH <br />                                                                                  ? <br />                                          HO                                                        2-O PO <br />                                                      O                                                3           O <br />  <br />                                                                             ATP          <span id='am-6' about='obo:IMR_0001360' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001349 obo:IMR_0000001 obo:IMR_0001698'><span id='am-7' property="rdfs:label" content="ADP" datatype="xsd:string"></span><span id='am-8' property="oboInOwl:hasDbXref" content="KEGG:C00008" datatype="xsd:string"></span><span id='am-9' property="oboInOwl:hasAlternativeId" content="IMR:0200375" datatype="xsd:string"></span><span id='am-10' property="oboInOwl:id" content="IMR:0001360" datatype="xsd:string"></span><span id='am-11' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>ADP</span> <br />                                                   OH     OH                                                      OH    OH <br />  <br />  <br />                                               pyrazofurin                                                pyrazofurin <br />                                                                                                         monophosphate <br />  <br />  <br /> Fig. 1. Key steps pyrimidine novo biosynthesis salvage pathways T. brucei. Orotate converted uridine monophosphate bifunctional UMP synthase (OPRT OMPDC). Uracil salvaged uridine phosphorylase (UPase) uridine uridine <br /> phosphoribosyl transferase (UPRT). pyrimidines transported specific pyrimidine transporter (U3). T. cruzi pyrazofurin proposed phosphorylated <span id='am-70' about='obo:IMR_0100126' typeof='owl:Thing obo:IMR_0000967 obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000965 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-71' property="oboInOwl:hasDbXref" content="KEGG:C00212" datatype="xsd:string"></span><span id='am-72' property="oboInOwl:hasExactSynonym" content="Adenine riboside" datatype="xsd:string"></span><span id='am-73' property="oboInOwl:hasExactSynonym" content="Ribofuranosyladenine" datatype="xsd:string"></span><span id='am-74' property="oboInOwl:hasAlternativeId" content="IMR:0200246" datatype="xsd:string"></span><span id='am-75' property="rdfs:label" content="Adenine riboside" datatype="xsd:string"></span><span id='am-76' property="rdfs:label" content="Adenosine" datatype="xsd:string"></span><span id='am-77' property="rdfs:label" content="adenosine" datatype="xsd:string"></span><span id='am-78' property="oboInOwl:hasExactSynonym" content="Adenosine" datatype="xsd:string"></span><span id='am-79' property="rdfs:label" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-80' property="obo:IAO_0000115" content="A nucleoside that is composed of adenine and d-ribose. Adenosine or adenosine derivatives play many important biological roles in addition to being components of DNA and RNA. Adenosine itself is a neurotransmitter." datatype="xsd:string"></span><span id='am-81' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-82' property="oboInOwl:hasExactSynonym" content="9-B-D-ribofuranosyl-9H-purin-6-amine" datatype="xsd:string"></span><span id='am-83' property="oboInOwl:id" content="IMR:0100126" datatype="xsd:string"></span><span id='am-84' property="rdfs:label" content="Ribofuranosyladenine" datatype="xsd:string"></span>adenosine</span> kinase order inhibit OMPDC (Hammond Gutteridge, 1983). structures R = H metabolites R = F antimetabolites 5-fluoroorotate 5-fluorouracil. <br />  <br />  <br /> produced positive&#226;&#8364;&#8220;negative selection                                                   enzyme annotated uridine monophosphate syn- <br /> genetic manipulation T. brucei (Scahill et al., 2008).                                              thase (UMPS, EC 2.4.2.10). OPRT OMPDC normal growth phenotype observed                                                 T. brucei comprise single bifunctional enzyme <br /> authors ascribed sufficient pyrimidines pro-                                              (Tb927.5.3810).  order fusion protein <br /> vided serum components standard medium,                                                  reversed  e. OMPDC-OPRT)  unusually, UMPS study open criticism Herpes simplex virus                                          T. brucei localized unique organelle, glyco- <br /> <span id='am-135' about='obo:IMR_0200384' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-136' property="rdfs:label" content="Thymidine" datatype="xsd:string"></span><span id='am-137' property="oboInOwl:id" content="IMR:0200384" datatype="xsd:string"></span><span id='am-138' property="oboInOwl:hasDbXref" content="KEGG:C00214" datatype="xsd:string"></span><span id='am-139' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>thymidine</span> kinase, broad substrate specificity                                                 cytosol (Hammond Gutteridge, deoxypyrimidines, used gene replacement                                                    1984). <br /> (Balzarini et al., 2002).  virulence vivo                                              Genetic chemically induced pyrimidine starvation <br /> assessed studies. final steps                                          results thymineless death prokaryotes eukary- <br /> novo biosynthesis, orotate converted orotidine                                             otes (Ahmad et al., 1998). effects reversed <br /> 5&#226;&#8364;&#178;-monophosphate (OMP) uridine 5&#226;&#8364;&#178;-monopho-                                                        supplementation pyrimidines taken <br /> sphate (UMP) enzymes orotidine phosphoribosyl                                                   growth medium salvage pathways. transferase (OPRT, EC 2.4.4.10) orotidine 5&#226;&#8364;&#178;-                                                      <span id='am-5' about='oboInOwl:date' typeof='owl:Thing'>date</span>, pyrimidine transport systems (U1, U2 C1) <br /> monophosphate decarboxylase (OMPDC, EC 4.1.1.23)                                                       identified biochemically insect stage respectively. OPRT OMPDC separate mono-                                                        T. brucei (Gudin et al., 2006).  additional <br /> functional enzymes bacteria certain para-                                                  uracil transporter (U3) identified mamma- <br /> sites, humans form single bifunctional                                               lian stage distinct procyclic transporters <br />  <br />                &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />                                                                                                       T. brucei UMP synthase drug target 445 <br />  <br />                                                                                   SacI       3.3 kb              SacI <br />  <br />                 kbp     WT     SKOHYG SKOPAC DKO                      UMPS                          UMPS <br />  <br />  <br />                 4                                                                 SacI     2.8 kb         SacI <br />  <br />                 3                                             &#206;&#8221;UMPS::HYG                            HYG <br />  <br />  <br />                                                                                    SacI   2.4 kb     SacI <br />                 2 <br />                                                                  &#206;&#8221;UMPS::PAC                    PAC <br />  <br />  <br /> Fig. 2. Genotypic analysis WT, SKO DKO cell lines. Southern blot analysis SacI-digested genomic DNA (&#226;&#710;&#188;5 &#206;&#188;g) diploid <br /> wild-type trypanosomes (WT), &#206;&#8221;UMPS::HYG (SKOHYG); &#206;&#8221;UMPS:PAC (SKOPAC); &#206;&#8221;UMPS::HYG/&#206;&#8221;UMPS::PAC (DKO) using probe 5&#226;&#8364;&#178;-UTR UMPS. schematic representation OMPDC locus gene replacements shown right blot. <br />  <br />  <br /> (Ali et al., 2013a). sole transporter expressed          DKO) generated replacing bloodstream forms U3 high-affinity uracil             second allelic copy PAC cloned line SKOHYG lower affinity uridine deoxyuridine (Ali            resistant hygromycin puromycin. geno- <br /> et al., 2013a). Trypanosomes lack uridine kinase activity            type respective stage confirmed Southern <br /> (Hammond Gutteridge, 1982), uridine              blot analysis genomic DNA (Fig. 2). SacI restric- <br /> verted uracil uridine phosphorylase uracil             tion endonuclease cuts genomic DNA 1950-bp <br /> subsequently converted UMP uracil phosphori-                  upstream 13-bp downstream UMPS open <br /> bosyltransferase. 5-fluoropyrimidine analogues                reading frame yielding &#226;&#710;&#188; 3.3 kbp fragment orotate, uridine uracil (R = F Fig. 1) follow        detected Southern analysis using probe pathway (Ali et al., 2013a). Plasma pyrimidine levels            5&#226;&#8364;&#178;-UTR. DKO cells, replaced fragments tightly regulated low micromolar range              &#226;&#710;&#188; 2.8 kbp (HYG) &#226;&#710;&#188; 2.4 kbp (PAC), indicating suc- <br /> thought novo biosynthesis required meet            cessful integration HYG PAC genes loss high demand pyrimidines rapidly dividing cells.               UMPS (Fig. 2). cells cultured hygro-  reasoned non-essentiality novo               mycin/puromycin-free media confirmation synthesis vitro apply vivo.                          validity umps null mutant. <br />    Using classical gene replacement nutritional <br /> rescue strategy, evaluated essentiality               Growth analyses umps null bloodstream <br /> UMPS, novo pyrimidine biosynthesis,                   T. brucei mutants <br /> T. brucei vitro vivo. Inhibitors target pyrimi- <br /> dine metabolism tested antitrypanoso-            ability generate propagate DKO cell line mal activity, including pyrazofurin, pro-drug              HMI9T agrees previous genome-wide study metabolized 5&#226;&#8364;&#178;-monophosphate-derivative,             RNAi UMPS non-essential vitro (Alsford et al., potent inhibitor mammalian OMPDC (Cadman et al.,                2011).  pyrimidines present normal culture <br /> 1978) (Fig. 1). findings indicate pyrimidine bio-           medium provided 10% fetal calf serum (FCS) 10% <br /> synthesis important growth parasites             Serum Plus  proprietary supplement containing 20% prolonged culture non-physiological medium               FCS unknown components) serving significantly alter virulence phenotype vivo pos-         metabolic bypass loss novo biosynthesis. <br /> sibly excreting orotate metabolized uridine          high concentration thymidine HMI9T host.                                                         sparing effect pyrimidine requirements                                                                      theoretically thymidine metabolized UMP                                                                      Neurospora crassa (Shaffer et al., 1975). Results                                                              HMI9T medium DKO cells grew marginally slower com- <br />                                                                      pared WT doubling times 6.2 5.5 h respec- <br /> Generation umps null mutants <br />                                                                      tively (Fig. 3, Table S1). Parasites HMI9T medium essentiality UMPS T. brucei examined                passaged trypanosome basal medium plus <br /> classical sequential gene replacement, using transfection            10% FCS (TBMFCS; essentially HMI9 Serum Plus drug-resistance genes selectable markers.                thymidine) determine cells require Serum Plus copy UMPS replaced HYG homo-                    growth. medium, doubling times slightly <br /> logous recombination generate single knockout                   increased 6.1 h (WT) 7.2 h (DKO) compared (SKOHYG) line resistant hygromycin. double knockout             cells grown HMI9T (Fig. 3, Table S1).  FCS null mutant (&#206;&#8221;UMPS::HYG/&#206;&#8221;UMPS::PAC, referred                    TBMFCS replaced 10% dialysed FCS completely <br />  <br /> &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />  446 H. B. Ong et al. &#226;&#8211;&#160; <br />  <br />  <br />  <br />  <br />                   Cumulative growth, cells ml -1 <br />  <br />  <br />  <br />  <br />                                                                                                                       Cumulative growth, cells ml -1 <br />                                                    10 21                                                                                               10 21 <br />                                                                                                                                                                  B <br />                                                    10 18                                                                                               10 18 <br />  <br />                                                    10 15                                                                                               10 15 <br />  <br />                                                    10 12                                                                                               10 12 <br />  <br />                                                    10 9                                                                                                10 9 <br />  <br />                                                    10 6                                                                                                10 6 <br />  <br />                                                    10 3                                                                                                10 3 <br />                                                            0       2       4      6    8    10      12   14                                                    0    2      4     6     8    10     12   14 <br />                                                                                  Time, days                                                                                     Time, days <br />  <br /> Fig. 3. Growth analyses WT DKO cells vitro. cumulative growth curves normalization dilution subculture WT <br />   DKO (B) cells determined weeks HMI9T (open circles), TBMFCS (closed circles) TBMdFCS (open squares). <br />  <br />  <br /> eliminate pyrimidines. conditions, WT cells                                                                      support growth DKO line concentrations continue grow robustly TBMdFCS increase                                                                 1 mM. uracil uridine effective doubling time (7.6 h), DKO cells unable                                                                     marked preference uracil uridine GC50 values <br /> grow perished day 4 (Fig. 3, Table S1). Growth                                                                 0.72 &#194;&#177; 0.04 &#206;&#188;M 250 &#194;&#177; 10 &#206;&#188;M respectively (Fig. 4B). DKO line restored supplementing TBMdFCS                                                                        Interestingly, uracil inhibit growth 100 &#206;&#188;M uracil uridine. presence uracil,                                                                    T. brucei concentrations &gt; 100 &#206;&#188;M. DKO cell line parasites able grow rate WT                                                                     &#226;&#710;&#188; 8-fold susceptible inhibition compared <br /> cells doubling time 7.4 h, growth                                                                      WT cells EC50 values 140 &#194;&#177; 5 &#206;&#188;M significantly slower (doubling time 17 h) uridine.                                                                   1140 &#194;&#177; 150 &#206;&#188;M respectively. similar effect noted <br /> Supplementation uracil uridine marginally                                                                       uridine, growth inhibition observed  <br /> enhances growth WT cells (Table S1). parallel                                                                       centrations 2.5 mM. <br /> study TBMFCS TBMdFCS containing 160 &#206;&#188;M thymidine <br /> confirmed thymidine effect growth WT <br />                                                                                                                              Evaluation UMPS drug target T. brucei DKO lines (Table S1). <br />                                                                                                                              variety inhibitors known disrupt pyrimidine <br />                                                                                                                              metabolism examined effects various <br /> Requirement pyrimidine supplementation <br />                                                                                                                              T. brucei cell lines TBMFCS. inhibitors include investigate pyrimidine requirement, WT                                                                      pyrazofurin, 5-fluoroorotic acid, 5-fluorouracil, 5-fluorou- DKO trypanosomes cultured TBMdFCS supple-                                                                        ridine, 5-bromodeoxyuridine 6-azauridine. Pyrazo- <br /> mented varying concentrations pyrimidine                                                                             furin  pyrazofurin monophosphate) potent inhibitor <br /> bases (cytosine, <span id='am-60' about='obo:IMR_0200036' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-61' property="oboInOwl:hasDbXref" content="KEGG:C00178" datatype="xsd:string"></span><span id='am-62' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-63' property="rdfs:label" content="Thymine" datatype="xsd:string"></span><span id='am-64' property="oboInOwl:id" content="IMR:0200036" datatype="xsd:string"></span>thymine</span>, uracil) corresponding                                                                    OMPDC organisms including Trypano- <br /> nucleosides (<span id='am-34' about='obo:IMR_0200161' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-35' property="rdfs:label" content="Cytidine" datatype="xsd:string"></span><span id='am-36' property="oboInOwl:hasDbXref" content="KEGG:C00475" datatype="xsd:string"></span><span id='am-37' property="oboInOwl:id" content="IMR:0200161" datatype="xsd:string"></span><span id='am-38' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>cytidine</span>, thymidine, uridine) (Fig. 4). Cyto-                                                                   soma cruzi (Hammond Gutteridge, 1983), sine, cytidine, thymine thymidine unable                                                                         5-fluoroorotate analogue orotate requires <br />                     Relative Fluorescence Units <br />  <br />  <br />  <br />  <br />                                                                                                                Relative Fluorescence Units <br />  <br />  <br />  <br />  <br />                                                    40,000                                                                                            40,000       B <br />  <br />  <br />  <br />                                                    20,000                                                                                              20,000 <br />  <br />  <br />  <br />  <br />                                                                0                                                                                               0 <br />                                                                    0.01    0.1    1    10   100 1,000 10,000                                                       0.01   0.1    1    10   100 1,000 10,000 <br />                                                                                  [Pyrimidine], &#194;&#181;M                                                                               [Pyrimidine], &#194;&#181;M <br />  <br /> Fig. 4. Growth WT DKO cells cultured varying concentrations uracil uridine.  WT cells. <br /> B. DKO cells. Symbols: plus uracil (open circles) uridine (closed circles). <br />  <br />                &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />                                                                                                                                                   T. brucei UMP synthase drug target 447 <br />  <br /> Table 1. EC50 values inhibitors (&#206;&#188;M) different cell lines cultured TBMFCS. <br />  <br />                                                    WT                                                      SKOHYG                                                   DKO <br />  <br /> Pyrazofurin                                        0.55 &#194;&#177; 0.02                                             0.42 &#194;&#177; 0.08                                              0.42 &#194;&#177; 0.03 <br /> 5-Fluoroorotic acid                                2.27 &#194;&#177; 0.14                                             1.92 &#194;&#177; 0.21                                              &gt; 100 <br /> 5-Fluorouracil                                     11.7 &#194;&#177; 0.52                                             8.45 &#194;&#177; 0.86                                              0.64 &#194;&#177; 0.08 <br /> 5-Fluorouridine                                    &gt; 100                                                   &gt; 100                                                    &gt; 100 <br /> 5-Bromodeoxyuridine                                &gt; 100                                                   &gt; 100                                                    &gt; 100 <br /> 6-Azauridine                                       &gt; 100                                                   &gt; 100                                                    &gt; 100 <br /> Eflornithine                                       10.5 &#194;&#177; 0.30                                             7.49 &#194;&#177; 0.17                                              8.70 &#194;&#177; 0.26 <br /> Pentamidine                                        0.88 (&#195;&#8212; 10&#226;&#710;&#8217;3) &#194;&#177; 0.03                                    1.17 (&#195;&#8212; 10&#226;&#710;&#8217;3) &#194;&#177; 0.03                                     0.97 (&#195;&#8212; 10&#226;&#710;&#8217;3) &#194;&#177; 0.03 <br />  <br /> Results means &#194;&#177; SEM triplicate measurements. <br />  <br />  <br />  <br /> metabolism UMPS produce 5-FUMP,                                                cells, DKO parasites &#226;&#710;&#188; 18-fold sensitive. <br /> incorporated RNA sugar nucleotides (Chaudhuri                                             cell types completely insensitive uridine <br /> et al., 1958; Santoso Thornburg, 1992). Like 5-                                                analogues, sensitivity standard drugs eflorni- <br /> fluorouracil 5-fluorouridine, 5-fluoroorotate                                       thine pentamidine unchanged. Addition converted FdUMP, inhibiting thymidylate synthase                                             160 &#206;&#188;M thymidine medium did affect sensitivity  disrupting DNA metabolism mammalian                                               pyrazofurin, 5-fluoroorotate 5-fluorouracil. <br /> cells (Pinedo Peters, 1988). WT T. brucei cells sensitive inhibitors: <br />                                                                                                    Virulence DKO parasites mice <br /> pyrazofurin, 5-fluoroorotate 5-fluorouracil (Table 1). <br /> Surprisingly, little change potency observed                                          Mammalian blood plasma contains micromolar levels pyrazofurin tested DKO SKOHYG                                                 pyrimidines, primarily uridine cells. addition, sensitivity WT cells affected                                       preferred <span id='am-65' about='obo:IMR_0001697' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001698'><span id='am-66' property="oboInOwl:id" content="IMR:0001697" datatype="xsd:string"></span><span id='am-67' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-68' property="rdfs:label" content="nucleoside" datatype="xsd:string"></span><span id='am-69' property="oboInOwl:hasDbXref" content="CHEBI:25611" datatype="xsd:string"></span>nucleoside</span> taken cells (Karle et al., 1981; supplementation uridine, uracil orotate (Fig.                                           Moyer et al., 1985).  T. brucei utilize <br /> S2). results suggest pyrazofurin inhibit-                                        uridine efficiently, non-physiological levels ing OMPDC T. brucei growth inhibition possibly                                           nucleoside required growth (Fig. 4). mind, target effect. case 5-fluoroorotate,                                       essentiality pyrimidine biosynthesis virulence DKO cells completely resistant inhibitor,                                             parasites examined animal model consistent requirement UMPS convert                                                  infection. Groups mice inoculated WT 5-fluoroorotate 5-FUMP. SKO cells displayed                                             DKO parasites grown TBMFCS. para- <br /> similar sensitivity 5-fluorouracil compared WT                                         sitaemia survival mice monitored <br />  <br />  <br />                                                                                B                                                           C <br />               100                                                      100                                                             100 <br />  <br />                80                                                      80                                                               80 <br />                                                          Survival, % <br /> Survival, % <br />  <br />  <br />  <br />  <br />                                                                                                                          Survival, % <br />  <br />  <br />  <br />  <br />                60                                                      60                                                               60 <br />  <br />                40                                                      40                                                               40 <br />  <br />                20                                                      20                                                               20 <br />  <br />                 0                                                        0                                                               0 <br />                     0   5   10      15   20   25    30                       0       5   10      15   20     25     30                       0     5      10      15     20      25      30 <br />                                  Time, days                                                   Time, days                                                       Time, days <br />  <br /> Fig. 5. Virulence parasites mice. Groups 5 mice infected intraperitoneally WT DKO parasites various culturing <br /> conditions.  Virulence T. brucei cultured TBMFCS. Inoculum: 104 WT parasites (open circles) 104 DKO parasites (closed circles) <br /> B. Virulence T. brucei prolonged culture HMI9T. Inoculum: WT parasites 104 (open circles) 106 (open squares); DKO parasites <br /> 104 (closed circles) 106 (closed squares). <br /> C. Virulence DKO parasites short-term culture TBMFCS plus thymidine versus HMI9T. Inoculum: 104 WT parasites cultured HMI9T <br /> (open squares); 104 DKO parasites cultured HMI9T (open circles) TBMFCS plus thymidine (closed circles). group mice infected 104 DKO parasites isolated infected mouse panel B (closed squares). Infections studies monitored period 30 days data presented form Kaplan&#226;&#8364;&#8220;Meier survival plot. <br />  <br /> &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />  448 H. B. Ong et al. &#226;&#8211;&#160; <br />  period 30 days (Fig. 5A). Mice infected WT           mouse died day 12. Surprisingly, DKOM parasites <br /> parasites achieved terminal parasitaemia &gt; 108 ml&#226;&#710;&#8217;1            highly infectious behaved like WT para- day 4, mice infected DKO parasites           sites. animals succumbed infection days 5 <br /> remained completely free parasites 30 days.               8, waves parasitaemia observed result suggests UMPS essential virulence           second study noticeably absent.  mice T. brucei mice.                                               infected stabilate DKO line    subculturing HMI9T 4 months,              cultured weeks remained parasite-free <br /> animal studies repeated. eliminate            30 days regardless medium possible discrepancy regarding viability para-           cultured  Collectively, findings reinforced sites cultured richer HMI9T versus TBMFCS               results animal study UMPS essential affect virulence. addition,              virulence survival T. brucei vivo. <br /> groups mice infected higher dose T. brucei (106 cells) investigate inoculum- <br /> dependent effect infectivity. Mice infected             Pyrimidine growth requirements <br /> higher inoculum (106 parasites) WT parasites suc- <br />                                                                     address differences virulence original DKO <br /> cumbed infection earlier, day 3 day 4 <br />                                                                     cell line subjected prolonged cultur- <br /> (104 parasites) (Fig. 5B).  results observed <br />                                                                     ing infectious DKOM, examined ability mice infected DKO parasites unexpected. <br />                                                                     various pyrimidines support growth (Table 2). Uracil, <br /> Mice infected higher dose DKO parasites went <br />                                                                     uridine, UMP deoxyuridine supported robust growth waves detectable, terminal, para- <br />                                                                     GC50 values micromolar range. Pseudouridine, <br /> sitaemia  e. &gt; 105 &lt; 108 ml&#226;&#710;&#8217;1) starting day 2                                                                     degradation product RNA, supported growth  <br /> succumbing infection days 7 8. Mice infected <br />                                                                     centrations 500 &#206;&#188;M, unable deter- lower dose showed detectable parasitaemia                                                                     accurate GC50 value pyrimidine mice commencing 8 days inocula- <br />                                                                     limited solubility. cells grew extent tion. positive mice underwent second wave <br />                                                                     cytidine concentrations 1 5 mM, GC50 non-terminal parasitaemia reaching terminal <br />                                                                     value determined toxicity parasitaemia days 15 16. fourth mouse                                                                     5 mM. Total RNA yeast (1 mg ml&#226;&#710;&#8217;1) inactive. infected day 20, reaching terminal para- <br />                                                                     Thymidine, thymine, cytosine dihydrouracil sitaemia day 24, final mouse remained <br />                                                                     unable support growth concentrations 1 mM. <br /> parasite-free entire 30 days. Parasites                                                                     GC50 values similar cell <br /> mice subsequently isolated cultured HMI9T <br />                                                                     types, consistent minor difference cells <br /> medium. Analysis cells Southern blotting <br />                                                                     grown uracil pyrimidines, revealed UMPS absent indicating infec- <br />                                                                     DKOM line unable achieve maximum <br /> tions accidental contamination                                                                     density DKO line (Fig. 6A). exception WT parasites (Fig. S1). Furthermore, parasites <br />                                                                     uridine (Fig. 6B). Differences maximum cell density <br /> remained auxotrophic pyrimidines; requirement <br />                                                                     observed parasites cultured uracil uridine supplementation suscepti- <br />                                                                     HMI9T TBMFCS doubling times identical bility 5-fluorouracil pyrazofurin changed. <br />                                                                     media provided cells subcultured    Contrary animal study, second study <br />                                                                     days. Collectively, results suggest suggests novo pyrimidine synthesis                                                                     subtle change pyrimidine metabolism provided <br /> essential parasite survival vivo.  ability <br />                                                                     advantage DKOM cells survival animals umps null mutants infect mice depend- <br />                                                                     compromised growth culture. <br /> ent overall health inoculum e. culture  <br /> ditions prior infection. definitively address possibility, vivo study carried (Fig. 5C). <br />                                                                     Uracil uridine transport stabilate original DKO sub- <br /> jected prolonged culture vitro used establish          kinetics uridine uracil transport investi- <br /> cultures TBMFCS HMI9T. Groups mice             gated determine upregulation pyrimidine inoculated 104 DKO parasites cultured           uptake contribute virulence survival (Fig. 7). <br /> medium infectivity compared mice infected             Uptake uracil linear 2 min obeys <br /> WT DKO parasites isolated mice (DKOM)                simple Michaelis Menten kinetics. Km values second study, cultured HMI9T.            significantly different, Vmax DKO DKOM lines mice infected WT parasites succumbed            (Table 2) marginally increased &#226;&#710;&#188; 1.4 &#226;&#710;&#188; 1.2- <br /> parasitaemia day 4 following infection,           fold respectively. contrast, transport kinetics  <br />                &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />                                                                                                                                                                                       T. brucei UMP synthase drug target 449 <br />  <br /> Table 2. comparison pyrimidine metabolism transport WT, DKO DKOM trypanosomes. <br />  <br /> Parameter                                                       Units                                     WT                                                            DKO                                 DKOM <br />  <br /> Pyrimidine GC50 <br />   Uracil                                                        &#206;&#188;M                                        N                                                            0.81 &#194;&#177; 0.04 (3)                     0.36 &#194;&#177; 0.03 (3) <br />   Uridine                                                       &#206;&#188;M                                        N                                                             190 &#194;&#177; 10 (2)                        779 &#194;&#177; 70 (2) <br />   UMP                                                           &#206;&#188;M                                        N                                                             295 &#194;&#177; 10 (3)                        320 &#194;&#177; 20 (3) <br />   Deoxyuridine                                                  &#206;&#188;M                                        N                                                             235 &#194;&#177; 10 (3)                        259 &#194;&#177; 4 (3) <br /> Transport kinetics <br />   Uracil Vmax                                                   pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1                     0.52 &#194;&#177; 0.02                                                   0.75 &#194;&#177; 0.06                         0.64 &#194;&#177; 0.04 <br />   Km                                                            &#206;&#188;M                                         0.28 &#194;&#177; 0.04                                                   0.51 &#194;&#177; 0.14                         0.36 &#194;&#177; 0.10 <br />   Uridine Vmax                                                  pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1                      101 &#194;&#177; 6                                                        96 &#194;&#177; 16                            100 &#194;&#177; 10 <br />   Km                                                            &#206;&#188;M                                        2,300 &#194;&#177; 500                                                   2,400 &#194;&#177; 1,500                       3,000 &#194;&#177; 1,100 <br /> Orotate production <br />   HMI9 medium                                                   pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1                    0                                                              5.91 &#194;&#177; 0.16 (3)                     6.75 &#194;&#177; 0.14 (3) <br />   TBMdFCS                                                       pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1                    0                                                              6.80 &#194;&#177; 0.25 (3)                     8.61 &#194;&#177; 0.29 (3) <br /> Orotate toxicity <br />   EC50                                                          &#206;&#188;M                                             153 &#194;&#177; 6 (2)                                              Non-toxica                          Non-toxica <br />   growth inhibition 1 mM. <br /> Results weighted means &#194;&#177; SEM (number experiments parentheses). <br />  <br />  <br />  <br />  <br /> uridine significantly different WT,                                                                                       concentration orotate spent medium DKOM <br /> DKO DKOM trypanosomes.                                                                                                                     cells noted consistently higher compared                                                                                                                                                DKO parasites experiments. difference <br />                                                                                                                                                prominent 96 h  30 &#194;&#177; 1.2 &#206;&#188;M <br /> Orotate production cells <br />                                                                                                                                                35 &#194;&#177; 1.7 &#206;&#188;M DKO DKOM respectively, n = 2, investigate differences pyrimidine                                                                                     P = 0.07). establish DKOM parasites utilization DKO DKOM cells vitro, spent                                                                                     producing orotate, log phase cells (&#226;&#710;&#188; 3 &#195;&#8212; <br /> media following 72 h culture analysed HPLC.                                                                                         106 cells ml&#226;&#710;&#8217;1) cultured HMI9T harvested, washed <br /> Consistent requirement salvage pyrimidines                                                                                     resuspended fresh medium 1 &#195;&#8212; 107 cells ml&#226;&#710;&#8217;1. <br /> growth, DKO cell lines took uracil WT                                                                                        Media samples collected regular intervals parasites (Fig. 8A). differences cytidine,                                                                                    analysed orotate production (Fig. 9A). rate cytosine thymidine levels spent medium                                                                                       orotate production DKO cells HMI9T linear cell types. Uridine levels spent medium                                                                                     time 6 h (2.26 &#194;&#177; 0.07 &#206;&#188;M h&#226;&#710;&#8217;1, weighted accurately quantified presence 1 mM                                                                                       means 3 independent experiments) slowed <br /> <span id='am-105' about='obo:IMR_0200173' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-106' property="rdfs:label" content="Hypoxanthine" datatype="xsd:string"></span><span id='am-107' property="oboInOwl:id" content="IMR:0200173" datatype="xsd:string"></span><span id='am-108' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-109' property="oboInOwl:hasDbXref" content="KEGG:C00262" datatype="xsd:string"></span>hypoxanthine</span> elutes closely uridine                                                                                          reaching 19.2 &#194;&#177; 0.45 &#206;&#188;M 12 h. initial <br /> interferes analyses.                                                                                                                  rate orotate production DKOM cells &#226;&#710;&#188; 1.1-fold <br />    striking observation analyses                                                                                          higher (2.39 &#194;&#177; 0.05 &#206;&#188;M h&#226;&#710;&#8217;1) achieving maximum &#226;&#710;&#188; 1.4- <br /> presence orotic acid spent medium DKO                                                                                             fold higher 12 h (26.6 &#194;&#177; 1.31 &#206;&#188;M). difference DKOM, WT, cells (Fig. 8B). 72 h,                                                                                         orotate production cell types                                                                                                                  Relative Fluorescence Units <br />                  Relative Fluorescence Units <br />  <br />  <br />  <br />  <br />                                                                                                                                                         B <br />                                                40,000                                                                                          40,000 <br />  <br />  <br />  <br />  <br />                                                20,000                                                                                          20,000 <br />  <br />  <br />  <br />  <br />                                                    0                                                                                               0 <br />                                                    0.001       0.01     0.1        1         10   100   1000                                       0.01       0.1   1         10     100    1000   10000 <br />                                                                               [Uracil], &#194;&#181;M                                                                              [Uridine], &#194;&#181;M <br />  <br /> Fig. 6. Growth DKO DKOM cells varying concentrations uracil uridine.  Growth varying concentrations uracil. <br /> B. Growth varying concentrations uridine. Symbols: DKO (open circles) DKOM (closed circles). <br />  <br /> &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />  450 H. B. Ong et al. &#226;&#8211;&#160; <br />  <br />                                                                 0.8 <br />  <br />  <br />  <br />  <br />                                 -1 <br />  <br />  <br />  <br />  <br />                                                                                                                                       -1 <br />                                                                                                                                                                        100 <br />  <br />  <br />  <br />  <br />                                 Uptake, pmol s -1 [108 cells] <br />                                                                            <br />  <br />  <br />  <br />                                                                                                                                       Uptake, pmol s -1 [108 cells] <br />                                                                                                                                                                                  B <br />                                                                 0.6                                                                                                     80 <br />  <br />                                                                                                                                                                         60 <br />                                                                 0.4 <br />  <br />                                                                                                                                                                         40 <br />                                                                 0.2 <br />                                                                                                                                                                         20 <br />  <br />                                                                  0                                                                                                       0 <br />                                                                       0                               2                 4         6                                          0           10,000        20,000        30,000 <br />                                                                                                           [Uracil], &#194;&#181;M                                                                      [Uridine], &#194;&#181;M <br />  <br /> Fig. 7. Uptake uracil uridine.  Uptake 0.07 &#206;&#188;M 3H-uracil presence varying concentrations unlabelled uracil. <br /> B. Uptake 0.5 &#206;&#188;M 3H-uridine presence varying concentrations unlabelled uridine. <br /> Symbols: WT (open circles) DKOM (closed squares) DKO (open squares). <br />  <br />  <br />                                                                                                                                                                       apparent cells incubated pyrimidine-free <br />                     3                                                                               15        B                                                     medium (TBMdFCS, Fig. 9B; Table 2). rate                                                                                                                                                                       orotate production DKO cells remained unchanged <br /> Concentration, &#194;&#181;M <br />  <br />  <br />  <br />  <br />                                                                                   Concentration, &#194;&#181;M <br />  <br />  <br />  <br />  <br />                                                                                                                                                                       (2.44 &#194;&#177; 0.10 &#206;&#188;M h&#226;&#710;&#8217;1), rate DKOM cells <br />                     2                                                                                 10                                                              increased &#226;&#710;&#188; 1.3-fold (3.12 &#194;&#177; 0.10 &#206;&#188;M h&#226;&#710;&#8217;1, n = 3, <br />                                                                                                                                                                       P = 0.001). peak amounts orotate 12 h                                                                                                                                                                       determined 19.6 &#194;&#177; 0.12 &#206;&#188;M 29.9 &#194;&#177; 0.64 &#206;&#188;M <br />                                                                                                                                                                       respectively. results suggest DKOM cells                     1                                                                                     5 <br />                                                                                                                                                                       able produce orotate DKO cells                                                                                                                                                                       able increase rate orotate pro- <br />                                                                                                                                                                       duction pyrimidine-free environment. character- <br />                     0                                                                                     0                                                           istics confer DKOM cells advantage <br />                           WT DKO DKOM                                                                          WT DKO DKOM <br />                                                                                                                                                                       DKO cells relation infection survival                         Uracil utilization                                                                    Orotate production <br />                                                                                                                                                                       mouse host. <br /> Fig. 8. Utilization uracil production orotate. Cells cultured HMI9T initial seeding density 1 &#195;&#8212; 103 cells ml&#226;&#710;&#8217;1, medium harvested 72 h analysed HPLC. B                                                                                                        Discussion uracil utilized orotate produced WT <br /> (closed bars), DKO (open bars) DKOM (gray bars) cells.                                                                                                        results current study demonstrate UMPS <br /> respective cell densities stage 7.2 &#195;&#8212; 106 cells ml&#226;&#710;&#8217;1 (WT) 3.2 &#195;&#8212; 106 cells ml&#226;&#710;&#8217;1 (DKO DKOM). initial concentration <br />                                                                                                                                                                       essential growth bloodstream T. brucei uracil medium 4.43 &#194;&#177; 0.26 &#206;&#188;M.                                                                                                                           pyrimidine-depleted medium. Growth supported  <br />  <br />                                                                 30                                                                                                      30 <br />  <br />                                                                                                                                                                                B <br />                                                                                                                                                        Orotate, &#194;&#181;M <br />                                Orotate, &#194;&#181;M <br />  <br />  <br />  <br />  <br />                                                                 20                                                                                                      20 <br />  <br />  <br />  <br />  <br />                                                                 10                                                                                                      10 <br />  <br />  <br />  <br />  <br />                                                                  0                                                                                                       0 <br />                                                                       0       2                       4         6    8      10   12                                          0       2     4       6     8      10    12 <br />                                                                                                               Time, h                                                                             Time, h <br />  <br /> Fig. 9. Overproduction orotate umps null mutants. Log-phase cells cultured HMI9T harvested, washed resuspended fresh medium 1 &#195;&#8212; 107 cells ml&#226;&#710;&#8217;1. Medium harvested various specified time intervals analysed HPLC. production orotate time DKO (open squares) DKOM (closed squares) cells measured HMI9T   TBMdFCS (B). <br />  <br />                              &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />                                                                                                  T. brucei UMP synthase drug target 451 <br />  <br /> uracil, uridine, deoxyuridine UMP robustly          potently inhibits OMPDC activity (Hammond pseudouridine cytidine (UMP presumed                   Gutteridge, 1983).  identical potency metabolized uridine extracellular nucleotidases           pyrazofurin various cell lines tested indi- <br /> phosphatases prior uptake). pyrimidines           cates OMPDC primary target T. brucei <br /> dihydrouracil, cytidine, cytosine, thymine thymidine did        anti-trypanosomal properties support growth. pyrimidine requirements               target&#226;&#8364;&#8482; effects. deserves investigation. <br /> bloodstream T. brucei entirely consistent recent              biochemical changes account transport studies report uracil uridine          lack infectivity DKO parasites mice? GC50 <br /> taken bloodstream forms single transporter,            transport Km values obtained vitro suggest designated U3, distinct insect stage          uracil preferred uridine vivo. Radiolabel- <br /> transporters U1, U2 C1 (Ali et al., 2013a). uracil         ling studies mice indicate [5-3H]-uracil rapidly uridine transport kinetic parameters good               catabolized trace salvaged nucleo- <br /> agreement published values.                               tides (Moyer et al., 1985). Unfortunately, reliable informa- <br />    Loss UMPS activity DKO results             tion plasma concentration uracil mice biochemical differences compared WT trypano-                  lacking, &#226;&#710;&#188; 0.1 &#206;&#188;M humans (Coudore et al., 2012). <br /> somes.  uracil transport capacity DKO cells               concentration uracil mice equivalent increases 1.4-fold associated fivefold               humans, case uridine (Moyer et al., 1981), <br /> increase utilization uracil medium meet          uracil level (GC50 0.81 &#206;&#188;M) insuf- nutritional requirements. Based uracil depletion            ficient support growth. Based transport data medium, rate uracil utilization             DKO cell uracil mouse plasma estimated 0.96 pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1, consistent       0.12 pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1, considerably transport Vmax uracil 0.75 pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1.      estimated growth, e. 0.96 pmol s&#226;&#710;&#8217;1 <br /> Second, biosynthetic intermediate, orotate,                 (108 cells)&#226;&#710;&#8217;1. serum concentration uridine mouse <br /> secreted medium large amounts DKO,              plasma range 2 5 &#206;&#188;M, uridine (GC50 WT cells. Notably, flux              190 &#206;&#188;M) low support growth. pathway orotate [5.9 pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1] exceeds        upper plasma concentration DKO cell uracil estimated growth HMI9T sixfold.         uridine 0.2 pmol s&#226;&#710;&#8217;1 (108 cells)&#226;&#710;&#8217;1, slightly higher addition, extracellular orotate toxic WT,         uracil. despite fact Km Vmax DKO cells (Table 2). suggests toxicity         pyrimidines differ orders magnitude, rates conversion excess orotate UMP pyrimi-              uptake physiological conditions predicted dine nucleotides. indicates regulation          similar.  important note transport novo synthesis occur earlier pathway.              uridine physiological levels present plasma regulatory mechanism unknown trypanosomatids,                proportional uridine concentration [S] &lt; &lt; Km.  mammalian cells, occurs feedback inhibi-          Based current information, contribution deoxyu- <br /> tion <span id='am-120' about='obo:IMR_0200199' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-121' property="oboInOwl:hasDbXref" content="KEGG:C00075" datatype="xsd:string"></span><span id='am-122' property="oboInOwl:id" content="IMR:0200199" datatype="xsd:string"></span><span id='am-123' property="rdfs:label" content="UTP" datatype="xsd:string"></span><span id='am-124' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span>UTP</span> protein phosphorylation            ridine, UMP pyrimidines growth impossible <br /> multifunctional enzyme pathway, CAD (Evans              quantify.  concluded total <br /> Guy, 2004).  complete loss inhibitory activity        rate salvage uridine plus uracil [0.32 pmol s&#226;&#710;&#8217;1 (108 5-fluororotate DKO trypanosomes indicates               cells)&#226;&#710;&#8217;1] estimated molecule converted 5-FUMP UMPS              required normal growth. exert toxicity. conversion incorporation            explanations surprising discov- UDP-sugars RNA, deoxyuridine                 ery DKO trypanosomes regained infectivity mice, <br /> nucleotides DNA, suggests mode action                    having maintained long-term culture? does involve inhibition thymidylate synthase (Ali           carried extensive investigations try answer et al., 2013a). supported fact dhfr-ts         question. genes enzymes involved pyrimidine <br /> null mutants equally sensitive 5-fluororotate               salvage (cytidine deaminase, thymidine kinase, uracil <br /> (Sienkiewicz et al., 2008)  reported  thymi-           phosphoribosyltransferase uridine phosphorylase) <br /> dine effect growth sensitivity fluoropyrimi-          sequenced, identical WT, DKO dines. hypersensitivity DKO cells 5-fluorouracil         DKOM parasites. Upregulation pyrimidine transport explained increased transport salvage                noted umps null mutants compared WT, activity exogenous uracil fluorinated analogue.         DKOM DKO, unlikely account <br /> Finally, pyrazofurin studied potent inhibitor        difference virulence. significant finding OMPDC mammalian cells  monophosphate)                 increased production orotate, particularly undergone clinical trials anticancer agent.              pyrimidine-poor environment, revertant (DKOM) cell crude extracts T. cruzi supplemented ATP                line. doing  trypanosomes possibly hijack host <br />  <br /> &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />  452 H. B. Ong et al. &#226;&#8211;&#160; <br />  <br /> metabolism convert excess orotate uridine          vate. TBM supplemented bovine FCS pyrimidine nucleotides. Support hypothesis comes           dialysed bovine FCS  PAA laboratories) fact administration orotate rats results     pyrimidines detailed text. Cell densities seeding <br />                                                                     cultures determined using CASY TT cell counter small (twofold) sustained increase plasma uridine <br />                                                                     (Sch&#195;&#164;rfe). cytidine levels (Gasser et al., 1981; Rosenfeldt et al., <br /> 1998). noted  transport uridine increases <br /> linearly changes extracellular concentration         Generation knockout constructs physiological range, doubling plasma uridine             PCR primers used generate constructs genetic <br /> level double rate uptake. small,           manipulation designed using T. brucei UMPS statistically significant increase orotate production        sequence GeneDB (Tb927.5.3810) template (Table DKOM DKO cells sufficient account             S2). accuracy assembled constructs verified differences virulence open debate,           sequencing. Replacement cassettes generated clear foregoing discussion subtle differences         amplifying region DNA encompassing 5&#226;&#8364;&#178;-untranslated <br />                                                                     region (UTR), open reading frame 3&#226;&#8364;&#178;-UTR UMPS pyrimidine levels tip balance death <br />                                                                     genomic DNA primers 5&#226;&#8364;&#178;-UTR-NotI_s 3&#226;&#8364;&#178;-UTR- survival parasite mouse.                           NotI_as, using Pfu polymerase. sequence    review process manuscript, similar          used template amplification individual <br /> knockout study published largely agrees              regions used assembly replacement cassettes  findings (Ali et al., 2013b). authors          taining selectable drug resistance genes puromycin UMPS-deficient T. brucei infectious            N-acetyl transferase (PAC) hygromycin phosphotrans- <br /> animal model. model proposing upregula-              ferase (HYG), exactly previously described (Martin                                                                     Smith, 2005). <br /> tion uracil transport compensatory mechanism retain virulence conceivable, noteworthy DKOM cells marginally decreased uracil transport             Generation T. brucei transgenic mutants <br /> compared DKO parasites. importantly,              Knockout constructs prepared using QIAprep Miniprep <br /> authors employed H. simplex virus thymidine kinase                  Plasmid Kit (Qiagen). Plasmids linearized using NotI, <br /> (HSVTK) replace UMPS gene. enzyme                   precipitated ethanol resuspended sterile water <br /> broad substrate specificity deoxynucleosides,             (1 &#206;&#188;g ml&#226;&#710;&#8217;1). Wild-type trypanosomes cultured HMI9T including deoxyuridine (Balzarini et al., 2002),              electroporated using programme X-001 Nucleofector II confounding effect pyrimidine metabo-               electroporator (Amaxa, Cologne, Germany) (Burkard et al., <br />                                                                     2007) following addition 5 &#206;&#188;g linearized DNA lism T. brucei. addition, deletion second allele <br />                                                                     reagents Human T cell Nucleofector kit manu- loss heterozygosity involved prolonged passage            facturers&#226;&#8364;&#8482; instructions. Parasites cloned limiting dilu- <br /> 5-fluoroorotate similar compensatory changes                 tion following transfection. generate double <br /> pyrimidine metabolism reported             knockout (DKO) UMPS, allele replaced occurred. Notwithstanding criticisms, studies            HYG. single knockout cell-line (SKOHYG) selected agree UMPS suitable drug target                culturing cells continuous presence hygromycin <br /> African trypanosome, case potential           (4 &#206;&#188;g ml&#226;&#710;&#8217;1). established, second UMPS allele                                                                     SKOHYG cells replaced PAC gene. resulting <br /> metabolic changes leading restoration virulence. <br />                                                                     DKO cell line selected culturing cells continuous <br />                                                                     presence hygromycin puromycin (0.1 &#206;&#188;g ml&#226;&#710;&#8217;1). <br /> Experimental procedures <br />                                                                     Southern blot analysis <br /> Organisms reagents <br />                                                                     5&#226;&#8364;&#178;-UTR T. brucei UMPS amplified PCR (using <br /> Pyrazofurin purchased Berry &amp; Associates  <br />                                                                     primers previously described generating knockout <br /> 3 <br />   H-uracil (36 Ci mmol&#226;&#710;&#8217;1) 3H-uridine (20 Ci mmol&#226;&#710;&#8217;1)                                                                     constructs) PCR DIG Probe Synthesis Kit <br /> purchased Perkin Elmer. Pseudouridine purchased <br />                                                                     (Roche). resulting digoxigenin-labelled product used Carbosynth. pyrimidines purchased Sigma <br />                                                                     probe. Southern analysis carried exactly Aldrich. chemicals reagents used study <br />                                                                     previously described (Wyllie et al., 2009) using samples highest grade purity available. Trypanosoma <br />                                                                     genomic DNA (5 &#206;&#188;g) digested restriction endonucle- <br /> brucei bloodstream-form &#226;&#8364;&#732;single marker&#226;&#8364;&#8482; S427 (T7RPOL <br />                                                                     ase SacI. <br /> TETR NEO) cultured 37&#194;&#176;C HMI9T (Greig et al., <br /> 2009), supplemented 2.5 &#206;&#188;g ml&#226;&#710;&#8217;1 G418 (Geneticin, <br /> Invitrogen). Trypanosome base media (TBM) derived                Concentration pyrimidines required half HMI11 (Hirumi Hirumi, 1989) consists                maximal growth <br /> Iscove&#226;&#8364;&#8482;s modified Dulbecco&#226;&#8364;&#8482;s MEM supplemented 0.05 mM bathocuproine, 1.5 mM cysteine, 1 mM hypoxan-               ability different pyrimidines support growth thine, 0.2 mM 2-mercaptoethanol 1 mM sodium pyru-               DKO lines investigated pyrimidine-free TBM <br />  <br />                &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />                                                                                                      T. brucei UMP synthase drug target 453 <br />  <br /> supplemented 10% dialysed fetal calf serum (TBMdFCS).          Microfuge tubes flash frozen liquid nitrogen concentration various pyrimidines required support        tubes containing cell pellets snipped <br /> growth determined 96 microtitre plates final       directly scintillation vials. Pellets solubilized culture volume 200 &#206;&#188;l initial parasite           1 M NaOH (150 &#206;&#188;l) overnight mixed scintillation fluid <br /> seeding density 2.5 &#195;&#8212; 103 cells ml&#226;&#710;&#8217;1. Stock solutions cyti-   (2 ml) radioactivity determined using liquid scin- <br /> dine, thymidine, uridine, pseudouridine, deoxyuridine           tillation counter. Uptake 3H-uridine (0.5 &#206;&#188;M) pres- <br /> UMP prepared water, cytosine, thymine, uracil,          ence varying concentrations unlabelled uridine (195 dihydrouracil torula yeast total RNA (Sigma Aldrich)       25 000 &#206;&#188;M) similarly determined, transport termi- <br /> dissolved 1 mM NaOH. Appropriate amounts solvent              nated time intervals (60, 120, 300, 450 600 s). included control wells. Cultures incubated 72 h cell density determined using resazurin- <br /> based assay (Raz et al., 1997; Jones et al., 2010).         Analysis purines pyrimidines media serum <br /> centration pyrimidine required support 50% <br />                                                                     Purines pyrimidines samples analysed HPLC <br /> maximum cell growth (GC50) determined plotting cell <br />                                                                     previously described (Tavazzi et al., 2005). Analytes density versus pyrimidine concentration analysed                                                                     separated ODS-2 Hypersil column (Thermo) using 4-parameter non-linear regression using GraFit. <br />                                                                     Dionex UltiMate 3000 coupled Dionex UltiMate <br />                                                                     3000 variable UV detector. Samples mobile phase                                                                     prepared previously described (Tavazzi et al., 2005), EC50 determination inhibitors                                                                     exception tetrabutylammonium hydroxide pyrimidine metabolism                                               mobile phases replaced tetrabutylammonium phos- <br />                                                                     phate (Sigma). <br /> EC50 values inhibitors determined using parasites <br /> cultured TBM plus 10% FCS (TBMFCS), thymidine. concentration inhibitors inhibit 50%           Measurement orotic acid production medium <br /> growth determined 96 microtitre plates final <br /> culture volume 200 &#206;&#188;l initial parasite           Log-phase cells (3 &#195;&#8212; 106 cells ml&#226;&#710;&#8217;1) cultured HMI9T seeding density 2.5 &#195;&#8212; 103 cells ml&#226;&#710;&#8217;1. wells, including       harvested centrifugation (800 g, 10 min, 4&#194;&#176;C), washed <br /> controls, contained 0.5% DMSO. EC50 values deter-              fresh HMI9T TBMdFCS resuspended mined described                                            1 &#195;&#8212; 107 cells ml&#226;&#710;&#8217;1). Cultures incubated 37&#194;&#176;C 5% <br />                                                                     CO2. time intervals 1, 2, 4, 6, 8 12 h, aliquots                                                                     cultures (500 &#206;&#188;l) removed medium separated vivo studies                                                     cells centrifugation (800 g, 10 min, 4&#194;&#176;C), treated                                                                     orotate levels measured HPLC. Orotate production animal experiments subject local ethical review         time analysed linear regression Grafit. Statistical performed Animals (Scientific Procedures) Act         analyses carried using Student&#226;&#8364;&#8482;s t-test 1986 accordance European Communities Council            samples equal variance. P &lt; 0.05 considered statistically <br /> Directive (86/609/EEC). lines parasites cultured        significant. routinely passaged HMI9T TBMFCS plus thymidine. avoid G418 toxicity mice, trypanosomes cultured absence G418 4&#226;&#8364;&#8220;12 h prior inoculation.             Acknowledgements <br /> Groups mice injected intraperitoneally specified number parasites, infections parasitae-       thank members Drug Discovery Unit biology team <br /> mia monitored period 30 days previously                initial screening data pyrazofurin Claire Paxton described (Sienkiewicz et al., 2008). Animals reaching            assistance preparation gene knockout  <br /> lethal parasitaemia (&gt; 108 ml&#226;&#710;&#8217;1) humanely killed           structs. work funded Wellcome Trust (079838 <br /> recorded having died day.                                801938). <br />  <br />  <br /> Pyrimidine transport                                                References <br /> Transport uracil uridine carried previously      Ahmad, S , Kirk, S.H., Eisenstark,  (1998) Thymine <br /> described (Wallace et al., 2002) modifications.              metabolism thymineless death prokaryotes T. brucei cells cultured HMI9T harvested centrifu-          eukaryotes. Annu Rev Microbiol 52: 591&#226;&#8364;&#8220;625. <br /> gation (800 g, 10 min, 4&#194;&#176;C), washed resuspended                 Ali, J , Creek, D.J., Burgess, K., Allison, H.C., Field, M.C., <br /> (1 &#195;&#8212; 108 cells ml&#226;&#710;&#8217;1) transport buffer (Ali et al., 2013b).          Maser, P., Koning, H.P. (2013a) Pyrimidine salvage <br /> Transport assays initiated addition 100 &#206;&#188;l cells        Trypanosoma brucei bloodstream forms trypano- 100 &#206;&#188;l pyrimidine microfuge tubes room tempera-             cidal action halogenated pyrimidines. Mol Pharmacol 83: <br /> ture. Uptake 3H-uracil (0.07 &#206;&#188;M) determined              439&#226;&#8364;&#8220;453. <br /> presence varying concentrations unlabelled uracil (0.08       Ali, J , Tagoe, D.N., Munday, J.C., Donachie, , Morrison, 5 &#206;&#188;M). specific time intervals (30, 60, 90, 120 150 s)       L.J., Koning, H.P. (2013b) Pyrimidine biosynthesis <br /> transport terminated centrifugation (16 000 g, 1 min)           essential function Trypanosoma brucei blood- silicone oil (200 &#206;&#188;l, Medford Silicones ).                 stream forms. PLoS 8: E58034. <br />  <br /> &#194;&#169; 2013 Authors. Molecular Microbiology published John Wiley &amp; Sons , Molecular Microbiology, 90, 443&#226;&#8364;&#8220;455 <br />  454 H. B. Ong et al. &#226;&#8211;&#160; <br />  <br /> Alsford, S., Turner, D.J., Obado, S.O., Sanchez-Flores, ,           Trypanosoma brucei blood stream forms medium  <br />   Glover, L., Berriman, M., et al. (2011) High-throughput phe-        taining low concentration serum protein feeder <br />   notyping using parallel sequencing Rna interference              cell layers. J Parasitol 75: 985&#226;&#8364;&#8220;989. <br />   targets African trypanosome. Genome Res 21: 915&#226;&#8364;&#8220;           Jones, D.C., Ariza, , Chow, W.H., Oza, S.L., Fairlamb, <br />   924.                                                                H. (2010) Comparative structural, kinetic inhibitor <br /> Arakaki, T.L., Buckner, F.S., Gillespie, J.R., Malmquist, N ,       studies Trypanosoma brucei trypanothione reductase <br />   Phillips, M , Kalyuzhniy, O., et al. (2008) Characteriza-         T. cruzi. Mol Biochem Parasitol 169: 12&#226;&#8364;&#8220;19. <br />   tion Trypanosoma brucei dihydroorotate dehydrogenase           Karle, J.M., Anderson, L.W., Dietrick, D.D., Cysyk, R.L. <br />   possible drug target; structural, kinetic Rnai             (1981) Effect inhibitors novo pyrimidine biosyn- <br />   studies. Mol Microbiol 68: 37&#226;&#8364;&#8220;50.                                   thetic pathway serum uridine levels mice. Cancer Res <br /> Balzarini, J., Liekens, S., Esnouf, R., Clercq, E.             41: 4952&#226;&#8364;&#8220;4955. <br />   (2002) A167Y mutation converts Herpes simplex             Martin, K., Smith, T.K. (2005) <span id='am-100' about='obo:IMR_0200177' typeof='owl:Thing obo:IMR_0000947 obo:IMR_0000001 obo:IMR_0001998'><span id='am-101' property="oboInOwl:id" content="IMR:0200177" datatype="xsd:string"></span><span id='am-102' property="rdfs:label" content="myo-Inositol" datatype="xsd:string"></span><span id='am-103' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-104' property="oboInOwl:hasDbXref" content="KEGG:C00137" datatype="xsd:string"></span>myo-inositol</span>-1- <br />   virus Type 1 thymidine kinase <span id='am-44' about='obo:IMR_0200445' typeof='owl:Thing obo:IMR_0001657 obo:IMR_0000947 obo:IMR_0001697 obo:IMR_0000001 obo:IMR_0001698'><span id='am-45' property="rdfs:label" content="guanosine" datatype="xsd:string"></span><span id='am-46' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-47' property="oboInOwl:hasDbXref" content="KEGG:C00387" datatype="xsd:string"></span><span id='am-48' property="oboInOwl:id" content="IMR:0200445" datatype="xsd:string"></span>guanosine</span> analogue             phosphate synthase gene essential Trypanosoma <br />   kinase. Biochemistry 41: 6517&#226;&#8364;&#8220;6524.                                 brucei. Biochem Soc Trans 33: 983&#226;&#8364;&#8220;985. <br /> Burkard, G., Fragoso, C.M., Roditi,  (2007) Highly            Moyer, J.D., Oliver, J.T., Handschumacher, R.E. (1981) <br />   efficient stable transformation bloodstream forms             Salvage circulating pyrimidine nucleosides rat. <br />   Trypanosoma brucei. Mol Biochem Parasitol 153: 220&#226;&#8364;&#8220;                 Cancer Res 41: 3010&#226;&#8364;&#8220;3017. <br />   223.                                                              Moyer, J.D., Malinowski, N., Ayers, O. (1985) Salvage Cadman, E.C., Dix, D.E., Handschumacher, R.E. (1978)              circulating pyrimidine nucleosides tissues mouse. <br />   Clinical, biological, biochemical effects pyrazofurin.       J Biol Chem 260: 2812&#226;&#8364;&#8220;2818. <br />   Cancer Res 38: 682&#226;&#8364;&#8220;688.                                           Pinedo, H.M., Peters, G.F.J. (1988) Fluorouracil &#226;&#8364;&#8220; <br /> Chaudhuri, N.K., Montag, B.J., Heidelberger, C. (1958)            biochemistry pharmacology. J Clin Oncol 6: 1653&#226;&#8364;&#8220; <br />   Studies fluorinated pyrimidines. iii. metabolism          1664. <br />   5-fluorouracil-2-C14 5-fluoroorotic-2-C14 acid vivo.       Raz, B., Iten, M., Grether-Buhler, Y., Kaminsky, R., Brun, <br />   Cancer Res 18: 318&#226;&#8364;&#8220;328.                                             R. (1997) Alamar Blue&#194;&#174; Assay determine drug <br /> Coudore, F., Roche, D., Lefeuvre, S., Faussot, D., Billaud,           sensitivity African trypanosomes (T. b. Rhodesiense   E.M., Loriot, M , Beaune, P. (2012) Validation          T. b. Gambiense) vitro. Acta Trop 68: 139&#226;&#8364;&#8220;147. <br />   ultra-high performance liquid chromatography tandem               Rosenfeldt, F.L., Richards, S.M., Lin, , Pepe, S.,   mass spectrometric method quantifying uracil 5,6-           Conyers, R J. (1998) Mechanism cardioprotective <br />   dihydrouracil human plasma. J Chromatogr Sci 50: 877&#226;&#8364;&#8220;            effect orotic acid. Cardiovasc Drugs Ther 12: 159&#226;&#8364;&#8220;170. <br />   884.                                                              Santoso, D., Thornburg, R.W. (1992) Isolation Evans, D.R., Guy, H  (2004) Mammalian pyrimidine                characterization UMP synthase mutants haploid <br />   biosynthesis: fresh insights ancient pathway. J Biol        cell-suspensions Nicotiana tabacum. Plant Physiol 99: <br />   Chem 279: 33035&#226;&#8364;&#8220;33038.                                              1216&#226;&#8364;&#8220;1225. <br /> Fairlamb, H. (2003) Chemotherapy human African trypa-          Scahill, M.D., Pastar, , Cross, G M. (2008) Cre <br />   nosomiasis: current future prospects. Trends Parasitol          recombinase-based positive-negative selection systems <br />   19: 488&#226;&#8364;&#8220;494.                                                        genetic manipulation Trypanosoma brucei. Mol <br /> Gasser, T., Moyer, J.D., Handschumacher, R.E. (1981)              Biochem Parasitol 157: 73&#226;&#8364;&#8220;82. <br />   Novel single-pass exchange circulating uridine rat-         Shaffer, P.M., Hsu, C , Abbott, M.T. (1975) Metabolism <br />   liver. Science 213: 777&#226;&#8364;&#8220;778.                                        pyrimidine deoxyribonucleosides Neurospora crassa. <br /> Greig, N., Wyllie, S., Patterson, S., Fairlamb, H. (2009)       J Bacteriol 121: 648&#226;&#8364;&#8220;655. <br />   comparative study methylglyoxal metabolism trypa-         Sienkiewicz, N., Jaroslawski, S., Wyllie, S., Fairlamb, <br />   nosomatids. FEBS J 276: 376&#226;&#8364;&#8220;386.                                    H. (2008) <span id='am-1' about='obo:IMR_0000947' typeof='owl:Thing obo:IMR_0000001'><span id='am-2' property="rdfs:label" content="chemical" datatype="xsd:string"></span><span id='am-3' property="oboInOwl:hasOBONamespace" content="molecule_role" datatype="xsd:string"></span><span id='am-4' property="oboInOwl:id" content="IMR:0000947" datatype="xsd:string"></span>Chemical</span> genetic validation dihydro- <br /> Gudin, S., Quashie, N.B., Candlish, D., Al-Salabi, M , Jarvis,      folate reductase-thymidylate synthase drug target   S.M., Ranford-Cartwright, L.C., Koning, H.P. (2006)          African trypanosomes. Mol Microbiol 69: 520&#226;&#8364;&#8220;533. <br />   Trypanosoma brucei: survey pyrimidine transport              Stuart, K.D., Brun, R., Croft, S.L., Fairlamb, H., Gurtler, <br />   activities. Exp Parasitol 114: 118&#226;&#8364;&#8220;125.             <br /> </body></html>